From the Department of Radiology, Memorial Sloan Kettering Cancer Center; and Department of Radiology, Weill Cornell Medical College, New York, NY.
Clin Nucl Med. 2019 Apr;44(4):330-331. doi: 10.1097/RLU.0000000000002467.
Ga-DOTATATE is a radiolabeled somatostatin analog used for the detection and characterization of somatostatin receptor (SSR)-overexpressing tumors, particularly well-differentiated neuroendocrine tumors. We present a case of a 65-year-old man with well-differentiated pancreatic neuroendocrine tumor post-Whipple surgery and a new liver lesion on CT. Ga-DOTATATE PET/CT was performed for SSR characterization and restaging, which demonstrated the lesion to be intensely SSR positive and interpreted as a neuroendocrine metastasis. However, subsequent pathology proved the lesion to be a hepatocellular carcinoma. This case adds hepatocellular carcinoma as a potentially DOTATATE-avid malignancy to be considered in the differential diagnoses of SSR-positive liver lesions.
镓- DOTATATE 是一种放射性标记的生长抑素类似物,用于检测和描述生长抑素受体 (SSR) 过表达的肿瘤,特别是分化良好的神经内分泌肿瘤。我们报告了一例 65 岁男性,在 Whipple 手术后患有分化良好的胰腺神经内分泌肿瘤,且 CT 上出现新的肝脏病变。进行 Ga-DOTATATE PET/CT 以进行 SSR 特征描述和分期,结果显示病变强烈 SSR 阳性,被解读为神经内分泌转移。然而,随后的病理证实该病变为肝细胞癌。该病例增加了肝细胞癌作为潜在的 DOTATATE 阳性恶性肿瘤,需要在 SSR 阳性肝脏病变的鉴别诊断中考虑。